These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

292 related articles for article (PubMed ID: 9129690)

  • 1. Tumor-associated angiogenesis: mechanisms, clinical implications, and therapeutic strategies.
    Pluda JM
    Semin Oncol; 1997 Apr; 24(2):203-18. PubMed ID: 9129690
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Implications of the new biology for therapy in breast cancer.
    Sledge GW
    Semin Oncol; 1996 Feb; 23(1 Suppl 2):76-81. PubMed ID: 8614850
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Angiogenesis and antiangiogenic cancer therapy].
    Pour L; Hájek R; Buchler T; Maisnar V; Smolej L
    Vnitr Lek; 2004 Dec; 50(12):930-8. PubMed ID: 15717808
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Angiogenesis of prostate cancer and antiangiogenic therapy.
    Uehara H
    J Med Invest; 2003 Aug; 50(3-4):146-53. PubMed ID: 13678383
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Tumor angiogenesis: biology and therapeutic prospects.
    Harris SR; Thorgeirsson UP
    In Vivo; 1998; 12(6):563-70. PubMed ID: 9891218
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical implications of tumor-associated neovascularization and current antiangiogenic strategies for the treatment of malignancies of pancreas.
    Pluda JM; Parkinson DR
    Cancer; 1996 Aug; 78(3 Suppl):680-7. PubMed ID: 8681307
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evading tumor evasion: current concepts and perspectives of anti-angiogenic cancer therapy.
    Abdollahi A; Folkman J
    Drug Resist Updat; 2010; 13(1-2):16-28. PubMed ID: 20061178
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Transcriptional switch of dormant tumors to fast-growing angiogenic phenotype.
    Almog N; Ma L; Raychowdhury R; Schwager C; Erber R; Short S; Hlatky L; Vajkoczy P; Huber PE; Folkman J; Abdollahi A
    Cancer Res; 2009 Feb; 69(3):836-44. PubMed ID: 19176381
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tumor angiogenesis--a potential target in cancer chemoprevention.
    Bhat TA; Singh RP
    Food Chem Toxicol; 2008 Apr; 46(4):1334-45. PubMed ID: 17919802
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Role of angiogenesis in the growth and progression of tumors. Treatment with angiogenesis inhibitors: from promising results in experimental animal models to the reality of clinical use].
    Plavetić ND; Letilović T; Vrbanec D
    Lijec Vjesn; 2003; 125(9-10):260-5. PubMed ID: 15038217
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Current development status of small-molecule vascular disrupting agents.
    Chaplin DJ; Horsman MR; Siemann DW
    Curr Opin Investig Drugs; 2006 Jun; 7(6):522-8. PubMed ID: 16784022
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tumor response to ionizing radiation combined with antiangiogenesis or vascular targeting agents: exploring mechanisms of interaction.
    Wachsberger P; Burd R; Dicker AP
    Clin Cancer Res; 2003 Jun; 9(6):1957-71. PubMed ID: 12796357
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Molecular mechanisms underlying tumor dormancy.
    Almog N
    Cancer Lett; 2010 Aug; 294(2):139-46. PubMed ID: 20363069
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Angiogenesis in cancer.
    Juczewska M; Chyczewski L
    Rocz Akad Med Bialymst; 1997; 42 Suppl 1():86-100. PubMed ID: 9337527
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Expression of vascular endothelial growth factor (VEGF) and VEGF receptors in tumor angiogenesis and malignancies.
    Pradeep CR; Sunila ES; Kuttan G
    Integr Cancer Ther; 2005 Dec; 4(4):315-21. PubMed ID: 16282508
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Therapeutic targeting of the tumor vasculature.
    Tozer GM; Bicknell R
    Semin Radiat Oncol; 2004 Jul; 14(3):222-32. PubMed ID: 15254865
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Recent progress in the development of anti-tumor metastatic drugs].
    Kumagai H
    Gan To Kagaku Ryoho; 1995 Apr; 22(5):585-91. PubMed ID: 7536403
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Angiogenic molecules and cancer metastasis.
    Kumar R; Fidler IJ
    In Vivo; 1998; 12(1):27-34. PubMed ID: 9575423
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Inhibition of tumor angiogenesis as a cancer treatment].
    Verheul HM; Bom JB; Hoekman K; Pinedo HM
    Ned Tijdschr Geneeskd; 1999 Jul; 143(30):1549-55. PubMed ID: 10443279
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antiangiogenesis therapy might have the unintended effect of promoting tumor metastasis by increasing an alternative circulatory system.
    Qu B; Guo L; Ma J; Lv Y
    Med Hypotheses; 2010 Feb; 74(2):360-1. PubMed ID: 19744799
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.